Related Experiment Video
Updated: Jul 7, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development
Martina Panattoni1, Francesca Sanvito, Veronica Basso
1Vita-Salute San Raffaele University School of Medicine, 20132 Milano, Italy.
Abstract:
Genetic programs promoting cell cycle progression, DNA repair, and survival are coordinately induced in developing T cells and require rapid turnover of effector molecules. As the COP9 signalosome (CSN) has been placed at the crossroads of these programs in lower organisms, we addressed its role by conditionally deleting CSN5/JAB1, its catalytic subunit, in developing thymocytes. CSN5/JAB1(del/del) thymocytes show defective S phase progression and massive apoptosis at the double-negative (DN) 4-double-positive (DP) transition stage, which is paralleled by altered turnover of selected CSN-controlled substrates, including p53, IkappaB-alpha, and beta-catenin. Combined dysregulation of the p53 and NF-kappaB pathways affects thymocyte survival by altering the mRNA and protein levels of selected Bcl-2 family members. Genetic complementation analysis performed on p53(-/-), Bcl-xL/Bcl-2A1, or T cell receptor transgenic backgrounds indicates that CSN5/JAB1 acts at distinct developmental stages to coordinate proliferation, survival, and positive selection of thymocytes by controlling the induction of defined genetic programs acting downstream of CSN-regulated transcription factors.
Insights
The COP9 signalosome subunit CSN5/JAB1 is crucial for T cell development. Its deletion causes thymocyte apoptosis by disrupting cell cycle progression and survival pathways.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Developing T cells require coordinated genetic programs for cell cycle progression, DNA repair, and survival.
- The COP9 signalosome (CSN) regulates these essential cellular processes in lower organisms.
- CSN5/JAB1 is the catalytic subunit of the CSN, implicated in crucial cellular functions.
Purpose of the Study:
- To investigate the role of CSN5/JAB1 in T cell development within the thymus.
- To understand how CSN5/JAB1 influences thymocyte proliferation, DNA repair, and survival.
- To elucidate the downstream targets and pathways regulated by CSN5/JAB1 during T cell maturation.
Main Methods:
- Conditional deletion of CSN5/JAB1 in developing thymocytes.
- Analysis of thymocyte proliferation, apoptosis, and cell cycle progression (S phase).
- Western blotting to assess turnover of CSN-controlled substrates (p53, IkappaB-alpha, beta-catenin).
- Genetic complementation studies using knockout and transgenic mouse models (p53, Bcl-xL/Bcl-2A1, TCR).
Main Results:
- CSN5/JAB1 deletion in thymocytes led to defective S phase progression and massive apoptosis at the DN4-DP transition.
- Altered turnover of key substrates including p53, IkappaB-alpha, and beta-catenin was observed.
- Dysregulation of p53 and NF-kappaB pathways impacted thymocyte survival by modulating Bcl-2 family members.
- CSN5/JAB1 controls distinct developmental stages, coordinating proliferation, survival, and positive selection.
Conclusions:
- CSN5/JAB1 is essential for normal T cell development, regulating critical checkpoints.
- The CSN catalytic subunit CSN5/JAB1 coordinates T cell maturation through controlled substrate turnover and pathway modulation.
- CSN5/JAB1 acts via downstream genetic programs controlled by CSN-regulated transcription factors to ensure thymocyte development.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inhibition of Cdk Activity
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Regulation of Hematopoietic Stem Cells
